AstraZeneca
The Associate Director, AI for Discovery — New Target Discovery role at AstraZeneca drives the adoption of agentic AI and predictive modeling tools to accelerate new target discovery across therapeutic areas. This hands-on position involves partnering with scientists to identify high-impact use cases, deploying multi-agent AI systems into workflows, and contributing to the development of predictive foundation models for in silico biology. The role requires deep technical expertise in AI and biology to influence cross-functional teams and shape scientific strategy.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
24% below the average for this role
Scientist II, Computational Biology, AI & Multimodal Target Discovery
PharmaEssentia
Target Validation Sr Director
Amgen
Bioinformatician - Computational Biology & AI Omics
ZIFO GmbH
Director of Artificial Intelligence
alnylam
Director, Discovery Bioinformatics Oncology
Eli Lilly and Company
Senior Director, Integrative Biology- Oncology Discovery
Johnson & Johnson Medical Korea Limited